Cargando…
Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning
Anxiety and depressive disorders are characterized by a number of clinical symptoms like decreased mood, apathy, anhedonia and anxiety. An important element of the clinical picture is also neurocognitive impairment. The most common treatment methods for depression and anxiety are pharmacology, psych...
Autores principales: | Krysta, Krzysztof, Krzystanek, Marek, Janas-Kozik, Małgorzata, Klasik, Adam, Krupka-Matuszczyk, Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529445/ https://www.ncbi.nlm.nih.gov/pubmed/25078256 http://dx.doi.org/10.1007/s00702-014-1282-3 |
Ejemplares similares
-
Sleep and inflammatory markers in different psychiatric disorders
por: Krysta, Krzysztof, et al.
Publicado: (2015) -
Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease (COPD): possible associations with inflammation markers: a pilot study
por: Bratek, Agnieszka, et al.
Publicado: (2014) -
Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis
por: Krysta, Krzysztof, et al.
Publicado: (2012) -
Cognitive deficits in adults with obstructive sleep apnea compared to children and adolescents
por: Krysta, Krzysztof, et al.
Publicado: (2016) -
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress
por: Kucukkarapinar, Melike, et al.
Publicado: (2022)